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Abstract
Red blood cell spectrin and its nonerythroid analogues are linked to integral proteins of the membrane by several skeletal protein
receptors, such as ankyrin and protein 4.1 together with p55. However, there are also many reasons for believing that they are insufficient to
engender all the properties that characterise the native membrane. Therefore, we are concerned with the mechanism by which brain spectrin
interacts with phospholipids of the membrane bilayer. Brain and erythrocyte spectrin were shown previously to bind phospholipid vesicles as
well as monolayers prepared from aminophospholipids: phosphatidylethanolamine and phosphatidylserine and their mixtures with
phosphatidylcholine (PC). In the present study, it is shown that brain spectrin binds to monolayers prepared from anionic phospholipids, such
as phosphatidylinositol (PI), phosphatidic acid (PA), phosphatidyl glycerol, diphosphatidylglycerol, and their mixtures with PC. Brain
spectrin injected into the subphase to reach nanomolar concentration induced a substantial increase in the surface pressure of monolayers
prepared from the phospholipids and their mixtures mentioned above, possibly by penetrating them. This effect is stronger in the case of
monolayers prepared from anionic phospholipids alone and weaker when monolayers were prepared from mixtures with PC. The weakest
effect was observed in the case of phosphatidylinositol-4,5-bisphosphate monolayers. An interaction of brain spectrin with monolayers
prepared from anionic phospholipids (PI/PC 7:3 and PA/PC 7:3) was inhibited (PI/PC much stronger than PA/PC) by purified erythrocyte
ankyrin, which indicates that the binding site for those lipids is located in the h-subunit, possibly in, or in close proximity of, the ankyrin-
binding site. In contrast, erythrocyte spectrin injected into the subphase induced a change in the surface pressure of monolayers prepared from
anionic phospholipids, which was equal or smaller than the value of surface pressure change induced by protein without a monolayer. This
effect was different from what had been observed previously for monolayers prepared from aminophospholipids and their mixtures with PC,
and from the data for nonerythroid spectrin presented here.
D 2002 Published by Elsevier Science B.V.
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1. Introduction
It is known that erythrocyte spectrin, one of the major
proteins of the mammalian red blood cell skeleton, interacts
directly with the lipid domain in natural membranes [1,2] or
in model systems [3–6]. This kind of interaction of red
blood cell spectrin with membrane lipid bilayers (or mono-
layers) has been known for 20 years, but its physiological
significance is still a matter of dispute. One of the possible
roles of this interaction would be serving as an alternative
binding site when there is not enough functional ankyrin to
accommodate all spectrin tetramers in the membrane, or its
affinity to bind spectrin is reduced, for example, upon
phosphorylation of ankyrin [7,8].
In our previous studies, we have observed interaction of
brain spectrin with membrane phospholipids studied on
natural (synaptic plasma) membranes [9] and on artificial
lipid mixtures formed from phospholipid liposomes and
monolayers [10,11]. We have found that brain spectrin binds
directly and rather strongly (KD in submicromolar range) to
liposomes containing aminophospholipids PE and PS and
phosphatidylcholine (PC) [10]. A monolayer study indicated
that the protein penetrates a monolayer, inducing an increase
in monolayer surface pressure [11]. The h-subunit of brain
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spectrin binds preferentially to the PE/PC phospholipid
monolayer mixtures. Inhibition of this binding by bovine
erythrocyte ankyrin indicates that the 15th repeat of the h-
subunit could take part in the interaction with lipid domains
of membranes [11].
The carboxyl-terminal segment of the h-subunit of brain
spectrin contains a pleckstrin homology (PH) domain,
approximately 100 amino acids long, which has also been
described as a membrane binding site [12]. The expressed,
purified PH domain binds to inositol-1,4,5-triphosphate
(IP3) vesicles as well as to vesicles containing phosphati-
dylinositol-4,5-bisphosphate (PIP2) [13].
To examine whether and how brain spectrin and its
erythrocyte analogue interacts with anionic phospholipids,
such as phosphatidylinositol (PI), PIP2, phosphatidic acid
(PA), phosphatidyl glycerol (PG) and bisphosphatidylgly-
cerol (DPG), we tested this interaction in monolayer experi-
ments. It was found that brain spectrin bound anionic
phospholipid monolayers by penetrating them (inducing
an increase in their surface pressure), while red blood cell
spectrin induced a change in the surface pressure of these
monolayers which was smaller from the value induced by
the protein without a lipid monolayer. Moreover, the effect
of brain spectrin on monolayers composed of PIP2 and its
mixtures with PC was very weak, indicating lack of engage-
ment of the PH domain. The inhibition of brain spectrin
binding to anionic phospholipid monolayers by ankyrin
suggests involvement of the ankyrin-binding domain in this
interaction.
2. Materials and methods
2.1. Materials
Sephacryl S-500-HR, Sephacryl S-200, DEAE-Sephacel,
Sepharose 4-B, dithiothreitol (DTT), ethylene glycol bis-(h-
aminoethyl ether) N,N,NV,NV-tetraacetic acid (EGTA), PI,
PIP2, DPG were from Sigma (St. Louis, MO). PA and PG
were from Lipids Products (Nutfield, UK).
2.2. Methods
Brain spectrin was isolated from bovine brains according
to Bennett et al. [14]. The final preparation, containing only
spectrin bands of apparent molecular weights of 280 and
267 kDa, with traces of a proteolytic 160-kDa fragment of
the a-spectrin subunit, was tested by SDS-polyacrylamide
gel electrophoresis in the Laemmli system [15].
Bovine erythrocyte spectrin was purified by the extrac-
tion of red blood cell ghosts with low ionic strength buffer
as described previously [16,17] and tested—as above. Iso-
lated proteins were dialysed overnight against an appropri-
ate buffer.
Pig erythrocyte ankyrin was isolated by the extraction of
red blood cell ghosts with low and high ionic strength buffer
according to Hall and Bennett [18], except that chromatog-
raphy was carried out on a FPLC ion exchanger chromatog-
raphy UNO-Q1 (Bio-Rad) column, using a linear gradient
(0–0.8 M) of NaCl in the presence of 2 M urea. To remove
traces of spectrin, ankyrin was purified by gel filtration on a
Sephacryl S-200 column (135 cm), equilibrated with 0.6
M KI in 7.5 mM Na2HPO4, 1 mM EDTA, 1 mM DTT, 1
mM NaN3, pH 8.0.
Monolayer measurements were carried out by using a
trough of surface area of 24 cm2 and a Nima tensiometer
(Nima Technology, England) at room temperature (20 jC).
Subphase buffer (25 ml) containing 5 mM Tris–HCl, 0.5
mM EDTA, 150 mM NaCl, 0.5 mM DTT and 1 mM NaN3,
pH 7.5, was stirred with a small stirrer bar (52 mm).
Monolayers were formed by the injection of a chloroform
solution of a phospholipid mixture with the use of a
Hamilton syringe. Aliquots of brain and red blood cell
spectrin dialysed against the same buffer were injected into
the subphase, and surface pressure (p) measurements were
taken.
For the experiments on the inhibition of brain spectrin–
phospholipid interaction by erythrocyte ankyrin, indicated
concentrations of ankyrin were first incubated with brain
spectrin for 30 min at room temperature, and then injected
into the subphase.
The data points represent average values of several
independent experiments with an average variation not
larger than 10%.
3. Results
In our study, we were concerned with brain spectrin
interaction with anionic phospholipids tested by the mono-
layer technique. The data on the interaction of brain and red
blood cell spectrin with anionic phospholipids had not been
available in the literature, therefore, the effect of both
spectrins on anionic phospholipid monolayers pressure
was tested.
In Fig. 1, we show an example of the original set of
measurements of changes in surface pressure of the PI/PC
(5:5) monolayer after the addition of brain spectrin (filled
symbols) and of erythrocyte spectrin (empty symbols) to the
subphase, for indicated initial surface pressure (pi) values.
Other data (Figs. 2–6) are presented as the dependence of
Dp versus pi for chosen spectrin concentrations (as indicated
in Figs. 2–6). It should be noted that the data represent Dp
from which the value of the protein adsorption without a
lipid monolayer for each concentration was subtracted.
The addition of bovine brain spectrin to the subphase
buffer induced an increase in the surface pressure (Dp) of
the PI monolayer at pH 7.5, which was a function of initial
surface pressure (pi) (Fig. 2A, filled symbols). The change
in surface pressure was increased for larger brain spectrin
concentrations and at a smaller initial surface pressure of the
PI monolayer. The brain spectrin concentration range evok-
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ing this effect was relatively low, that is, below 3 nM, which
might indicate a specific interaction. The same effect was
observed using a PI/PC monolayer prepared from mixtures
of PI/PC ratios 7:3 and 5:5 (Fig. 2B and C).
Fig. 2A–C (empty symbols) shows a change in the
surface pressure of the PI, PI/PC (7:3) and PI/PC (5:5)
monolayers upon addition of erythrocyte spectrin to the
subphase buffer as a function of initial surface pressure (pi).
As a result of these experiments, we observed negative
values of surface pressure (Dp) changes, when subtracted
from the value of protein adsorption to the surface without a
lipid monolayer. Moreover, we observed a larger decrease in
the change in surface pressure (Dp) for larger spectrin
concentrations and for larger initial surface pressure values
of the monolayer. In the case of erythroid spectrin, the
changes took place also at nanomolar concentrations.
We tested the effect of bovine brain spectrin on phos-
pholipid monolayer surface pressure also by using other
anionic phospholipids, such as PA and its mixtures PA/PC
(7:3) and PA/PC (5:5) (Fig. 3A–C), PG and its mixtures
PG/PC (7:3) and PG/PC (5:5) (Fig. 4A–C), and DPG and
its mixtures DPG/PC (7:3) and DPG/PC (5:5) (Fig. 5A–C).
In each case, we observed the same kind of changes in
surface pressure (Dp) of the phospholipid monolayer as a
function of initial surface pressure (pi): an increase in the
change in surface pressure (Dp) for larger spectrin concen-
trations and for smaller initial surface pressure of the tested
monolayer. In addition, injection of erythrocyte spectrin to
the subphase buffer induced the same linear decrease in
surface pressure of the monolayers described above, as a
function of initial surface pressure (pi), as in the case of PI
and its monolayer mixtures (Figs. 3–5, empty symbols).
In summary, it should be stated that brain spectrin in
nanomolar concentrations induced an increase in Dp which
was inversely proportional to the initial film pressure values
(pi). The largest Dp changes were observed in the case of
the PA/PC (7:3) and the smallest in the case of the DPG/PC
(5:5) monolayer. Erythrocyte spectrin, however, in nano-
molar concentrations induced Dp changes which were equal
or smaller than the value of the protein adsorption without a
lipid monolayer. These changes were larger at higher initial
surface pressure of the monolayer. These changes are
comparable with the data of others (e.g. Shiffer et al. [19])
for monolayers prepared from other lipid mixtures, as well
as for other proteins such as erythroid protein 4.1 and
spectrin, serum albumin, lysozyme, a-casein, and apolipo-
protein. The parameters of an ‘‘uncorrected’’ Dp value for
erythrocyte and brain spectrin at concentrations 5 and 2.5
nM, respectively, resulting from a linear fit of Dp= f(pi),
were similar to those of proteins of rather moderate hydro-
phobicity. For the brain spectrin, pi intercept values were
from 15 to over 33 mN/m, Dp intercept 6–25 mN/m and
slope between 0.24 and 1.59. For the erythroid spectrin,
these values were: 13–26 mN/m (pi intercept), 12–24.0
mN/m (Dp intercept) and slope 0.45–1.82 (data not shown).
The data previously obtained by others [12] indicate an
interaction of nonerythroid spectrin’s PH domain with PIP2-
containing vesicles. In this experimental system, this inter-
action was not well pronounced. In Fig. 6, we show the
results of a change in surface pressure of the PIP2, PIP2/PC
(7:3) and the PIP2/PC (5:5) monolayers at pH 7.5 upon the
addition of bovine brain spectrin to the subphase buffer as a
function of initial surface pressure (pi). The observed effect
was much weaker than the increase in surface pressure
observed upon the addition of brain spectrin to the subphase
of PI, PA, PG, DPG and their monolayer mixtures. It seems
that the effect is proportional to the PC concentration in the
monolayer. These results indicate a rather low capacity of
the PIP2-containing monolayers for nonerythroid spectrin
binding.
Fig. 1. Change in surface pressure (Dp) of the PI/PC 5:5 monolayer after the addition of brain spectrin (filled symbols) and of red blood cell spectrin (empty
symbols) to the subphase, at indicated initial surface pressure (pi) values. Values of the surface pressure change induced by the protein without a lipid
monolayer were subtracted from Dp.
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The measured changes in surface pressure of anionic
phospholipid monolayers as a function of pi after addition of
brain spectrin to the subphase and the other, earlier obtained
data [11], indicate the penetration of the monolayer film by
brain spectrin. One of possible approaches to the identifi-
cation of anionic phospholipid-binding sites in brain spec-
trin was to test whether the interaction of brain spectrin was
sensitive to inhibition by purified erythrocyte ankyrin. We
measured the effect of ankyrin on the binding by brain
spectrin to PI/PC 7:3 and PA/PC 7:3 monolayer mixtures.
Fig. 3. Change in surface pressure (Dp) of PA and its monolayer mixtures as
a function of initial surface pressure (pi) after the addition of indicated
concentrations of bovine brain and erythrocyte spectrin to the subphase.
Monolayers formed from: (A) PA, (B) PA/PC 7:3, (C) PA/PC 5:5. Other
details as in Fig. 1.
Fig. 2. Change in surface pressure (Dp) of PI and its monolayer mixtures as
a function of initial surface pressure (pi) after the addition of indicated
concentrations of bovine brain and erythrocyte spectrin to the subphase.
Monolayers formed from: (A) PI, (B) PI/PC 7:3, (C) PI/PC 5:5 (original
data presented in Fig. 1). Other details as in Fig. 1.
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The molar ratio of spectrin to ankyrin varied from 1:0.25 to
1:1. In control experiments, only brain spectrin at the same
concentration was added. Stronger inhibition of interaction
of brain spectrin with the PI/PC 7:3 monolayer by ankyrin
(approx. 50%) was observed in experiments at a 1:1 molar
ratio of brain spectrin to ankyrin. A weaker effect (approx.
30%) of inhibition of the interaction of brain spectrin with
monolayers by ankyrin was observed in experiments using
the PA/PC 7:3 monolayer. Dixon [20] type analysis (Fig. 7A
and B) indicates a competitive mechanism with two values
of KI = 0.603F0.134 (S.D.) and 1.181F0.23 (S.D.) nM for
Fig. 5. Change in surface pressure (Dp) of DPG and its monolayer mixtures
as a function of initial surface pressure (pi) after the addition of indicated
concentrations of bovine brain and erythrocyte spectrin to the subphase.
Monolayers formed from: (A) DPG, (B) DPG/PC 7:3, (C) DPG/PC 5:5.
Other details as in Fig. 1.
Fig. 4. Change in surface pressure (Dp) of PG and its monolayer mixtures
as a function of initial surface pressure (pi) after the addition of indicated
concentrations of bovine brain and erythrocyte spectrin to the subphase.
Monolayers formed from: (A) PG, (B) PG/PC 7:3, (C) PG/PC 5:5. Other
details as in Fig. 1.
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the PI/PC 7:3 monolayer mixture, and one value of
KI = 2.788F0.245 (S.D.) nM for the PA/PC 7:3 monolayer
mixture, respectively.
4. Discussion
Our previously obtained data demonstrate that brain
spectrin binds membrane phospholipids [10,11]. In the
experiments presented above, it is shown that this interac-
Fig. 7. Inhibition of the binding of bovine brain spectrin to the PI/PC 7:3
monolayers (A), and the PA/PC 7:3 monolayers (B) by erythrocyte ankyrin.
(A) Dixon [20] plot of the results obtained for 10 indicated concentrations
of brain spectrin. Two different KI values can be obtained: 0.603F 0.134
nM (meanFS.D.) for brain spectrin concentrations in the range of 0.6–1.5
and 1.181F 0.23 nM at brain spectrin concentrations over 1.5 nM. (B)
Dixon [20] plot of the results obtained for 6 indicated concentrations of
brain spectrin. A KI value can be obtained: 2.788F 0.245 nM (meanFS.D.)
for brain spectrin concentrations in the range of 0.6–2.8 nM.
Fig. 6. Change in surface pressure (Dp) of PIP2 and its monolayer mixtures
as a function of initial surface pressure (pi) after the addition of bovine brain
spectrin to the subphase. Monolayers from: (A) PIP2, (B) PIP2/PC 7:3, (C)
PIP2/PC 5:5. Brain spectrin concentrations in the subphase: (+) 0.59; (o)
1.17; (.) 1.73; (5) 2.1; (n) 2.47; (y) 2.83 and (D) 3.35 nM. Other details
as in Fig. 1.
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tion could be demonstrated also by monolayer experiments,
although it is difficult to extract quantitative parameters of
this interaction (KD and Bmax). Instead, applied methods
give an insight whether this interaction affects the properties
of the lipid layer. The results obtained by using nanomolar
concentrations of brain spectrin indicate that this protein
could penetrate phospholipid monolayers built from anionic
phospholipids, such as PI, PA, phosphatidylglycerol, DPG
and their mixtures with PC at the ratio of 7:3 and 5:5. The
observed effect was much stronger than in the case of PC
alone (see Ref. [11]). Moreover, the effect was independent
of the content of PC in the phospholipid–PC mixture
(compare Fig. 1 with Fig. 6).
An increase in the surface pressure of a phospholipid
monolayer would suggest its penetration by certain seg-
ments of brain spectrin molecules. Inhibition of this effect
by erythrocyte ankyrin (Fig. 7) suggests that the phospho-
lipid binding site could be located in the h-subunit, approx-
imately at the region of ankyrin binding [21]. These results
are similar to those obtained for the inhibition of erythrocyte
spectrin interaction with PE/PC vesicles and monolayers by
ankyrin [22,23], as well as to those observed for the
Fig. 8. Comparison of the ankyrin-binding domains of the h-subunit between erythroid spectrin, accession number P11277 (left panel) and nonerythroid
spectrin, accession number Q01082 (right panel), see Ref. [21]. Helical wheel presentation. Alignment of helices was taken from Ref. [26]. Charged residues
that are different in both sequences are boxed. Linking regions between helices A15 and B15 (erythroid spectrin residues 1822–1830, nonerythroid spectrin
residues 1830–1838) which differ by one positive charge (R1834) present in nonerythroid spectrin and B15 and C15 (erythroid spectrin residues 1863–1870,
nonerythroid spectrin residues 1871–1878) which are characterised by identical charge distribution are omitted.
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inhibition of interaction of brain spectrin with PE/PC
monolayers by ankyrin [11]. The reason for the lower
sensitivity of PA-containing monolayers to inhibition by
ankyrin is not known, but it could be suggested that a
smaller head group could account for this effect.
The data given by Wang and Shaw [12] indicate that the
PH domain may be involved in lipid binding, and that this
binding coincides with the inositol-1,4,5-trisphosphate bind-
ing site. These results, indicating an occurrence of other,
ankyrin-insensitive sites of phospholipid binding in the
spectrin molecule may suggest also functional connection
and spatial relationship between the ankyrin-binding site
and the PH domain.
In our experiments to determine the binding of brain
spectrin with the phospholipid monolayer formed from PIP2
and its mixtures with PC at the ratio of 7:3 and 5:5, we
observed a much smaller increase in surface pressure than in
that observed for the PI, PA, PG and DPG monolayers. The
results presented in Fig. 6 indicate much weaker penetration
of the PIP2 monolayer by brain spectrin than in the case of
the other anionic phospholipid mixtures. The lack of pen-
etration of PIP2-containing monolayers by brain spectrin is
probably due to head-group specificity of h-spectrin’s PH
domain [24]. It is also possible that in purified brain
spectrin, this domain is not exposed to the solution, there-
fore it does not bind this phospholipid.
Inhibition of the interaction of brain spectrin with anionic
phospholipid monolayers indicate an involvement of the h-
spectrin region close or identical to the ankyrin-binding
domain in this interaction. The obtained KI-values for
inhibition of brain spectrin interaction with PI-containing
monolayers are close to the values obtained for the PE/PC
monolayer binding by brain spectrin in the presence of
ankyrin [22], while higher values, calculated for PA-con-
taining monolayers, might reflect lower affinity of spectrin
to this monolayer, which might accompany the lower
capacity mentioned above.
All the monolayer experiments were performed using
relatively the same, low initial surface pressure values. The
results that we obtained (Figs. 1–5, empty symbols) indi-
cate changes in surface pressure upon addition of red blood
cell spectrin which were smaller from the surface pressure
values evoked by protein adsorption to the surface without
an anionic phospholipid monolayer. The effect is more
distinct for larger erythrocyte spectrin concentrations and
pi values of the monolayer. The observed surface pressure
values could indicate smaller penetration or even a com-
pression of the monolayer. This is somewhat surprising,
since the results observed previously indicated a great
similarity of the effects of both spectrins in monolayers
prepared from aminophospholipid and PC or their mixtures
[11,22].
A comparison of the charge of the ankyrin-binding
domain (residues 1768–1898) of red blood cell and brain
h-spectrin (1776–1906) [21] suggests that the domain of
erythrocyte protein contains six more negatively charged
amino acid residues than positively charged ones, while
brain spectrin contains only two net negative charges. When
this comparison is limited to the region of helix A15 and
fragment linking helix B15 erythrocyte spectrin contains
three net negative charges, while brain spectrin contains
three more positive residue than negative residues clustered
at the same region of the helix (Fig. 8). This possibly could
explain the difference in the effect of both proteins on
monolayers composed of anionic phospholipids and their
mixtures with PC.
Our data imply a strong, direct interaction between brain
spectrin and anionic membrane phospholipids. Its physio-
logical significance, however, is not completely clear, since
there are many kinds of proteinaceous binding sites in
nonerythroid (particularly neuronal) cell membranes. One
possibility is that lipidic binding sites are of particular
importance, while ankyrin is either absent or its spectrin-
binding activity has been reduced by, for example, phos-
phorylation [6,7]. Recent data [25] indicate a functional role
of aminophospholipid asymmetry in stabilisation of mem-
brane–membrane skeleton interactions. One of the sites of
those interactions could be formed by aminophospholipid-
rich domains or in particular, in the case of nonerythroid
spectrin by anionic phospholipid-rich domains.
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